McKesson Corp.
Moat Score — McKesson Corp.
Total Moat Score
13 / 30
| Moat Factor | Score | Analysis |
|---|---|---|
| Intangible Assets Patents, trademarks, brand strength, or regulatory licenses that protect a company's products or services from being freely copied by competitors. | 1 / 5 | McKesson has little consumer-facing brand value and no meaningful patent protection; its advantage is almost entirely operational scale and entrenched infrastructure rather than intangible assets. |
| Cost Advantage A durable ability to produce goods or services more cheaply than competitors — through scale, unique access to cheap inputs, location, or process — that lets a company undercut rivals or out-earn them at the same price. | 4 / 5 | Enormous logistics scale — warehouses, delivery fleets, and inventory systems built over decades — lets McKesson distribute pharmaceuticals at razor-thin per-unit costs that would be extraordinarily expensive for a new entrant to replicate nationwide. |
| Pricing Power The ability to raise prices without losing meaningful business, because the product or service is differentiated, mission-critical, or has few good substitutes. | 1 / 5 | Pharmaceutical distribution is a high-volume, low-margin pass-through business with pricing set largely by manufacturer contracts and payer/PBM pressure, leaving McKesson very little independent pricing power on its core business. |
| Network Effect The product or service becomes more valuable to every user as more people or organizations use it, making an established leader harder to displace. | 0 / 5 | Drug distribution logistics carry no network effect — the value of McKesson's supply chain to one pharmacy doesn't increase because more pharmacies use McKesson. |
| Switching Costs The money, time, or operational disruption a customer would face switching to a competitor, which locks in existing customers and supports renewals. | 3 / 5 | Hospitals and pharmacies build significant operational integration with their primary wholesaler (ordering systems, generic-sourcing programs, inventory management), but the oligopoly structure means large customers can and periodically do renegotiate or shift volume among McKesson, Cencora, and Cardinal Health. |
| Efficient Scale A market that can only profitably support a small number of players, so incumbents face limited threat from new entrants even without other defenses. | 4 / 5 | U.S. pharmaceutical distribution is a consolidated oligopoly of three players whose fixed-cost logistics networks are so large that a new entrant would struggle to earn an adequate return, reinforcing the incumbents' collective position. |